Selective attention – · people with attention deficits following stroke
2 findings from 1 review
Death from all causes within 30 days of surgery · patients with symptomatic or asymptomatic carotid disease
Shunting showed no clear difference in death from all causes within 30 days of surgery compared with no shunting (low certainty).
1 finding from 1 review
Stroke‐related death within 30 days of surgery (best‐case) · patients with symptomatic or asymptomatic carotid disease
Shunting may leads to lower stroke‐related death within 30 days of surgery (best‐case) compared with no shunting (low certainty).
1 finding from 1 review
Stroke‐related death within 30 days of surgery (worst‐case) · patients with symptomatic or asymptomatic carotid disease
Shunting showed no clear difference in stroke‐related death within 30 days of surgery (worst‐case) compared with no shunting (low certainty).
1 finding from 1 review
Any stroke during surgery (best‐case) · patients with symptomatic or asymptomatic carotid disease
Shunting showed no clear difference in any stroke during surgery (best‐case) compared with no shunting (low certainty).
1 finding from 1 review
Any stroke during surgery (worst‐case) · patients with symptomatic or asymptomatic carotid disease
Shunting showed no clear difference in any stroke during surgery (worst‐case) compared with no shunting (low certainty).
1 finding from 1 review
Any stroke within 24 hours of surgery · patients with symptomatic or asymptomatic carotid disease
Shunting may leads to lower any stroke within 24 hours of surgery compared with no shunting (low certainty).
1 finding from 1 review
Stroke · patients with symptomatic or asymptomatic carotid disease
Shunting showed no clear difference in any stroke within 30 days of surgery compared with no shunting (low certainty).
1 finding from 1 review
Disability (primary analysis) · people with stroke recovery
1 finding from 1 review
Independent on modified Rankin score (mRS 0 to 2) (primary analysis) · people with stroke recovery
Fluoxetine showed no clear difference in independent on modified Rankin score (mRS 0 to 2) (primary analysis) compared with control at end of treatment, (high certainty).
1 finding from 1 review
Neurological deficit score · people with stroke recovery
1 finding from 1 review
no estimate extracted
30 participants
Low
Depressive symptoms · people with stroke recovery
1 finding from 1 review
Death · people with stroke recovery
Fluoxetine showed no clear difference in death compared with control at end of treatment, (moderate certainty).
1 finding from 1 review
Seizures · people with stroke recovery
Fluoxetine showed no clear difference in number of seizures compared with control at end of treatment, (moderate certainty).
1 finding from 1 review
Fracture · people with stroke recovery
Fluoxetine leads to higher bone fractures compared with control at end of treatment, (high certainty).
1 finding from 1 review